Global Stroke Therapeutics Market Research Report 2023

Stroke Therapeutics Market

The global Stroke Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Stroke Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Stroke Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Stroke Therapeutics in Ischemic Stroke is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Stroke Therapeutics include Abbott Laboratories, Cordis, Boston Scientific, Siemens, Genentech, Koninklijke Philips, Medtronic, GE Healthcare and Stryker, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Stroke Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stroke Therapeutics.

The Stroke Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Stroke Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Stroke Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Scope of Stroke Therapeutics Market Report

Core Chapters

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Stroke Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Intravenous Injection

1.2.3 Oral

1.2.4 Others

1.3 Market by Application

1.3.1 Global Stroke Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Ischemic Stroke

1.3.3 Hemorrhagic Stroke

1.3.4 Transient Ischemic Attack

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Stroke Therapeutics Market Perspective (2018-2029)

2.2 Stroke Therapeutics Growth Trends by Region

2.2.1 Global Stroke Therapeutics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Stroke Therapeutics Historic Market Size by Region (2018-2023)

2.2.3 Stroke Therapeutics Forecasted Market Size by Region (2024-2029)

2.3 Stroke Therapeutics Market Dynamics

2.3.1 Stroke Therapeutics Industry Trends

2.3.2 Stroke Therapeutics Market Drivers

2.3.3 Stroke Therapeutics Market Challenges

2.3.4 Stroke Therapeutics Market Restraints

3.1 Global Top Stroke Therapeutics Players by Revenue

3.1.1 Global Top Stroke Therapeutics Players by Revenue (2018-2023)

3.1.2 Global Stroke Therapeutics Revenue Market Share by Players (2018-2023)

3.2 Global Stroke Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Stroke Therapeutics Revenue

3.4 Global Stroke Therapeutics Market Concentration Ratio

3.4.1 Global Stroke Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Stroke Therapeutics Revenue in 2022

3.5 Stroke Therapeutics Key Players Head office and Area Served

3.6 Key Players Stroke Therapeutics Product Solution and Service

3.7 Date of Enter into Stroke Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Stroke Therapeutics Historic Market Size by Type (2018-2023)

4.2 Global Stroke Therapeutics Forecasted Market Size by Type (2024-2029)

5.1 Global Stroke Therapeutics Historic Market Size by Application (2018-2023)

5.2 Global Stroke Therapeutics Forecasted Market Size by Application (2024-2029)

6.1 North America Stroke Therapeutics Market Size (2018-2029)

6.2 North America Stroke Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Stroke Therapeutics Market Size by Country (2018-2023)

6.4 North America Stroke Therapeutics Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Stroke Therapeutics Market Size (2018-2029)

7.2 Europe Stroke Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Stroke Therapeutics Market Size by Country (2018-2023)

7.4 Europe Stroke Therapeutics Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Stroke Therapeutics Market Size (2018-2029)

8.2 Asia-Pacific Stroke Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Stroke Therapeutics Market Size by Region (2018-2023)

8.4 Asia-Pacific Stroke Therapeutics Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Stroke Therapeutics Market Size (2018-2029)

9.2 Latin America Stroke Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Stroke Therapeutics Market Size by Country (2018-2023)

9.4 Latin America Stroke Therapeutics Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Stroke Therapeutics Market Size (2018-2029)

10.2 Middle East & Africa Stroke Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Stroke Therapeutics Market Size by Country (2018-2023)

10.4 Middle East & Africa Stroke Therapeutics Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Detail

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Stroke Therapeutics Introduction

11.1.4 Abbott Laboratories Revenue in Stroke Therapeutics Business (2018-2023)

11.1.5 Abbott Laboratories Recent Development

11.2 Cordis

11.2.1 Cordis Company Detail

11.2.2 Cordis Business Overview

11.2.3 Cordis Stroke Therapeutics Introduction

11.2.4 Cordis Revenue in Stroke Therapeutics Business (2018-2023)

11.2.5 Cordis Recent Development

11.3 Boston Scientific

11.3.1 Boston Scientific Company Detail

11.3.2 Boston Scientific Business Overview

11.3.3 Boston Scientific Stroke Therapeutics Introduction

11.3.4 Boston Scientific Revenue in Stroke Therapeutics Business (2018-2023)

11.3.5 Boston Scientific Recent Development

11.4 Siemens

11.4.1 Siemens Company Detail

11.4.2 Siemens Business Overview

11.4.3 Siemens Stroke Therapeutics Introduction

11.4.4 Siemens Revenue in Stroke Therapeutics Business (2018-2023)

11.4.5 Siemens Recent Development

11.5 Genentech

11.5.1 Genentech Company Detail

11.5.2 Genentech Business Overview

11.5.3 Genentech Stroke Therapeutics Introduction

11.5.4 Genentech Revenue in Stroke Therapeutics Business (2018-2023)

11.5.5 Genentech Recent Development

11.6 Koninklijke Philips

11.6.1 Koninklijke Philips Company Detail

11.6.2 Koninklijke Philips Business Overview

11.6.3 Koninklijke Philips Stroke Therapeutics Introduction

11.6.4 Koninklijke Philips Revenue in Stroke Therapeutics Business (2018-2023)

11.6.5 Koninklijke Philips Recent Development

11.7 Medtronic

11.7.1 Medtronic Company Detail

11.7.2 Medtronic Business Overview

11.7.3 Medtronic Stroke Therapeutics Introduction

11.7.4 Medtronic Revenue in Stroke Therapeutics Business (2018-2023)

11.7.5 Medtronic Recent Development

11.8 GE Healthcare

11.8.1 GE Healthcare Company Detail

11.8.2 GE Healthcare Business Overview

11.8.3 GE Healthcare Stroke Therapeutics Introduction

11.8.4 GE Healthcare Revenue in Stroke Therapeutics Business (2018-2023)

11.8.5 GE Healthcare Recent Development

11.9 Stryker

11.9.1 Stryker Company Detail

11.9.2 Stryker Business Overview

11.9.3 Stryker Stroke Therapeutics Introduction

11.9.4 Stryker Revenue in Stroke Therapeutics Business (2018-2023)

11.9.5 Stryker Recent Development

11.10 Merck

11.10.1 Merck Company Detail

11.10.2 Merck Business Overview

11.10.3 Merck Stroke Therapeutics Introduction

11.10.4 Merck Revenue in Stroke Therapeutics Business (2018-2023)

11.10.5 Merck Recent Development

11.11 Zocere, Inc.

11.11.1 Zocere, Inc. Company Detail

11.11.2 Zocere, Inc. Business Overview

11.11.3 Zocere, Inc. Stroke Therapeutics Introduction

11.11.4 Zocere, Inc. Revenue in Stroke Therapeutics Business (2018-2023)

11.11.5 Zocere, Inc. Recent Development

11.12 Acticor Biotech

11.12.1 Acticor Biotech Company Detail

11.12.2 Acticor Biotech Business Overview

11.12.3 Acticor Biotech Stroke Therapeutics Introduction

11.12.4 Acticor Biotech Revenue in Stroke Therapeutics Business (2018-2023)

11.12.5 Acticor Biotech Recent Development

11.13 DiaMedica Therapeutics

11.13.1 DiaMedica Therapeutics Company Detail

11.13.2 DiaMedica Therapeutics Business Overview

11.13.3 DiaMedica Therapeutics Stroke Therapeutics Introduction

11.13.4 DiaMedica Therapeutics Revenue in Stroke Therapeutics Business (2018-2023)

11.13.5 DiaMedica Therapeutics Recent Development

11.14 Lumosa Therapeutics

11.14.1 Lumosa Therapeutics Company Detail

11.14.2 Lumosa Therapeutics Business Overview

11.14.3 Lumosa Therapeutics Stroke Therapeutics Introduction

11.14.4 Lumosa Therapeutics Revenue in Stroke Therapeutics Business (2018-2023)

11.14.5 Lumosa Therapeutics Recent Development

11.15 AXONIS Therapeutics , Inc.

11.15.1 AXONIS Therapeutics , Inc. Company Detail

11.15.2 AXONIS Therapeutics , Inc. Business Overview

11.15.3 AXONIS Therapeutics , Inc. Stroke Therapeutics Introduction

11.15.4 AXONIS Therapeutics , Inc. Revenue in Stroke Therapeutics Business (2018-2023)

11.15.5 AXONIS Therapeutics , Inc. Recent Development

11.16 NovaGo Therapeutics

11.16.1 NovaGo Therapeutics Company Detail

11.16.2 NovaGo Therapeutics Business Overview

11.16.3 NovaGo Therapeutics Stroke Therapeutics Introduction

11.16.4 NovaGo Therapeutics Revenue in Stroke Therapeutics Business (2018-2023)

11.16.5 NovaGo Therapeutics Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Stroke Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Intravenous Injection

    Table 3. Key Players of Oral

    Table 4. Key Players of Others

    Table 5. Global Stroke Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Stroke Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Stroke Therapeutics Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Stroke Therapeutics Market Share by Region (2018-2023)

    Table 9. Global Stroke Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Stroke Therapeutics Market Share by Region (2024-2029)

    Table 11. Stroke Therapeutics Market Trends

    Table 12. Stroke Therapeutics Market Drivers

    Table 13. Stroke Therapeutics Market Challenges

    Table 14. Stroke Therapeutics Market Restraints

    Table 15. Global Stroke Therapeutics Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Stroke Therapeutics Market Share by Players (2018-2023)

    Table 17. Global Top Stroke Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stroke Therapeutics as of 2022)

    Table 18. Ranking of Global Top Stroke Therapeutics Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Stroke Therapeutics Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Stroke Therapeutics Product Solution and Service

    Table 22. Date of Enter into Stroke Therapeutics Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Stroke Therapeutics Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Stroke Therapeutics Revenue Market Share by Type (2018-2023)

    Table 26. Global Stroke Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Stroke Therapeutics Revenue Market Share by Type (2024-2029)

    Table 28. Global Stroke Therapeutics Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Stroke Therapeutics Revenue Market Share by Application (2018-2023)

    Table 30. Global Stroke Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Stroke Therapeutics Revenue Market Share by Application (2024-2029)

    Table 32. North America Stroke Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Stroke Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Stroke Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Stroke Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Stroke Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Stroke Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Stroke Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Stroke Therapeutics Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Stroke Therapeutics Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Stroke Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Stroke Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Stroke Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Stroke Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Stroke Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Stroke Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Abbott Laboratories Company Detail

    Table 48. Abbott Laboratories Business Overview

    Table 49. Abbott Laboratories Stroke Therapeutics Product

    Table 50. Abbott Laboratories Revenue in Stroke Therapeutics Business (2018-2023) & (US$ Million)

    Table 51. Abbott Laboratories Recent Development

    Table 52. Cordis Company Detail

    Table 53. Cordis Business Overview

    Table 54. Cordis Stroke Therapeutics Product

    Table 55. Cordis Revenue in Stroke Therapeutics Business (2018-2023) & (US$ Million)

    Table 56. Cordis Recent Development

    Table 57. Boston Scientific Company Detail

    Table 58. Boston Scientific Business Overview

    Table 59. Boston Scientific Stroke Therapeutics Product

    Table 60. Boston Scientific Revenue in Stroke Therapeutics Business (2018-2023) & (US$ Million)

    Table 61. Boston Scientific Recent Development

    Table 62. Siemens Company Detail

    Table 63. Siemens Business Overview

    Table 64. Siemens Stroke Therapeutics Product

    Table 65. Siemens Revenue in Stroke Therapeutics Business (2018-2023) & (US$ Million)

    Table 66. Siemens Recent Development

    Table 67. Genentech Company Detail

    Table 68. Genentech Business Overview

    Table 69. Genentech Stroke Therapeutics Product

    Table 70. Genentech Revenue in Stroke Therapeutics Business (2018-2023) & (US$ Million)

    Table 71. Genentech Recent Development

    Table 72. Koninklijke Philips Company Detail

    Table 73. Koninklijke Philips Business Overview

    Table 74. Koninklijke Philips Stroke Therapeutics Product

    Table 75. Koninklijke Philips Revenue in Stroke Therapeutics Business (2018-2023) & (US$ Million)

    Table 76. Koninklijke Philips Recent Development

    Table 77. Medtronic Company Detail

    Table 78. Medtronic Business Overview

    Table 79. Medtronic Stroke Therapeutics Product

    Table 80. Medtronic Revenue in Stroke Therapeutics Business (2018-2023) & (US$ Million)

    Table 81. Medtronic Recent Development

    Table 82. GE Healthcare Company Detail

    Table 83. GE Healthcare Business Overview

    Table 84. GE Healthcare Stroke Therapeutics Product

    Table 85. GE Healthcare Revenue in Stroke Therapeutics Business (2018-2023) & (US$ Million)

    Table 86. GE Healthcare Recent Development

    Table 87. Stryker Company Detail

    Table 88. Stryker Business Overview

    Table 89. Stryker Stroke Therapeutics Product

    Table 90. Stryker Revenue in Stroke Therapeutics Business (2018-2023) & (US$ Million)

    Table 91. Stryker Recent Development

    Table 92. Merck Company Detail

    Table 93. Merck Business Overview

    Table 94. Merck Stroke Therapeutics Product

    Table 95. Merck Revenue in Stroke Therapeutics Business (2018-2023) & (US$ Million)

    Table 96. Merck Recent Development

    Table 97. Zocere, Inc. Company Detail

    Table 98. Zocere, Inc. Business Overview

    Table 99. Zocere, Inc. Stroke Therapeutics Product

    Table 100. Zocere, Inc. Revenue in Stroke Therapeutics Business (2018-2023) & (US$ Million)

    Table 101. Zocere, Inc. Recent Development

    Table 102. Acticor Biotech Company Detail

    Table 103. Acticor Biotech Business Overview

    Table 104. Acticor Biotech Stroke Therapeutics Product

    Table 105. Acticor Biotech Revenue in Stroke Therapeutics Business (2018-2023) & (US$ Million)

    Table 106. Acticor Biotech Recent Development

    Table 107. DiaMedica Therapeutics Company Detail

    Table 108. DiaMedica Therapeutics Business Overview

    Table 109. DiaMedica Therapeutics Stroke Therapeutics Product

    Table 110. DiaMedica Therapeutics Revenue in Stroke Therapeutics Business (2018-2023) & (US$ Million)

    Table 111. DiaMedica Therapeutics Recent Development

    Table 112. Lumosa Therapeutics Company Detail

    Table 113. Lumosa Therapeutics Business Overview

    Table 114. Lumosa Therapeutics Stroke Therapeutics Product

    Table 115. Lumosa Therapeutics Revenue in Stroke Therapeutics Business (2018-2023) & (US$ Million)

    Table 116. Lumosa Therapeutics Recent Development

    Table 117. AXONIS Therapeutics , Inc. Company Detail

    Table 118. AXONIS Therapeutics , Inc. Business Overview

    Table 119. AXONIS Therapeutics , Inc. Stroke Therapeutics Product

    Table 120. AXONIS Therapeutics , Inc. Revenue in Stroke Therapeutics Business (2018-2023) & (US$ Million)

    Table 121. AXONIS Therapeutics , Inc. Recent Development

    Table 122. NovaGo Therapeutics Company Detail

    Table 123. NovaGo Therapeutics Business Overview

    Table 124. NovaGo Therapeutics Stroke Therapeutics Product

    Table 125. NovaGo Therapeutics Revenue in Stroke Therapeutics Business (2018-2023) & (US$ Million)

    Table 126. NovaGo Therapeutics Recent Development

    Table 127. Research Programs/Design for This Report

    Table 128. Key Data Information from Secondary Sources

    Table 129. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Stroke Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Stroke Therapeutics Market Share by Type: 2022 VS 2029

    Figure 3. Intravenous Injection Features

    Figure 4. Oral Features

    Figure 5. Others Features

    Figure 6. Global Stroke Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Stroke Therapeutics Market Share by Application: 2022 VS 2029

    Figure 8. Ischemic Stroke Case Studies

    Figure 9. Hemorrhagic Stroke Case Studies

    Figure 10. Transient Ischemic Attack Case Studies

    Figure 11. Stroke Therapeutics Report Years Considered

    Figure 12. Global Stroke Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 13. Global Stroke Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Stroke Therapeutics Market Share by Region: 2022 VS 2029

    Figure 15. Global Stroke Therapeutics Market Share by Players in 2022

    Figure 16. Global Top Stroke Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stroke Therapeutics as of 2022)

    Figure 17. The Top 10 and 5 Players Market Share by Stroke Therapeutics Revenue in 2022

    Figure 18. North America Stroke Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. North America Stroke Therapeutics Market Share by Country (2018-2029)

    Figure 20. United States Stroke Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Canada Stroke Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Stroke Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Stroke Therapeutics Market Share by Country (2018-2029)

    Figure 24. Germany Stroke Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. France Stroke Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. U.K. Stroke Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Italy Stroke Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Russia Stroke Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Nordic Countries Stroke Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Stroke Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Stroke Therapeutics Market Share by Region (2018-2029)

    Figure 32. China Stroke Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Japan Stroke Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. South Korea Stroke Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Southeast Asia Stroke Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. India Stroke Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Australia Stroke Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Stroke Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Stroke Therapeutics Market Share by Country (2018-2029)

    Figure 40. Mexico Stroke Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Brazil Stroke Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Stroke Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Stroke Therapeutics Market Share by Country (2018-2029)

    Figure 44. Turkey Stroke Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Saudi Arabia Stroke Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Abbott Laboratories Revenue Growth Rate in Stroke Therapeutics Business (2018-2023)

    Figure 47. Cordis Revenue Growth Rate in Stroke Therapeutics Business (2018-2023)

    Figure 48. Boston Scientific Revenue Growth Rate in Stroke Therapeutics Business (2018-2023)

    Figure 49. Siemens Revenue Growth Rate in Stroke Therapeutics Business (2018-2023)

    Figure 50. Genentech Revenue Growth Rate in Stroke Therapeutics Business (2018-2023)

    Figure 51. Koninklijke Philips Revenue Growth Rate in Stroke Therapeutics Business (2018-2023)

    Figure 52. Medtronic Revenue Growth Rate in Stroke Therapeutics Business (2018-2023)

    Figure 53. GE Healthcare Revenue Growth Rate in Stroke Therapeutics Business (2018-2023)

    Figure 54. Stryker Revenue Growth Rate in Stroke Therapeutics Business (2018-2023)

    Figure 55. Merck Revenue Growth Rate in Stroke Therapeutics Business (2018-2023)

    Figure 56. Zocere, Inc. Revenue Growth Rate in Stroke Therapeutics Business (2018-2023)

    Figure 57. Acticor Biotech Revenue Growth Rate in Stroke Therapeutics Business (2018-2023)

    Figure 58. DiaMedica Therapeutics Revenue Growth Rate in Stroke Therapeutics Business (2018-2023)

    Figure 59. Lumosa Therapeutics Revenue Growth Rate in Stroke Therapeutics Business (2018-2023)

    Figure 60. AXONIS Therapeutics , Inc. Revenue Growth Rate in Stroke Therapeutics Business (2018-2023)

    Figure 61. NovaGo Therapeutics Revenue Growth Rate in Stroke Therapeutics Business (2018-2023)

    Figure 62. Bottom-up and Top-down Approaches for This Report

    Figure 63. Data Triangulation

    Figure 64. Key Executives Interviewed